New dementia drugs and therapies: What Canadians should know
Growing hope over a new Alzheimer's drug, but there are side effects
Hope and anxiety surround new Alzheimer’s drug lecanemab
That Pricey New Alzheimer's Drug? Still Not Great
Drug to treat agitation in Alzheimer’s patients approved in Canada
New Alzheimer's drug shows promise in slowing disease
Alzheimer Society of Canada on New Experimental Drug
Debating the risks, benefits of a controversial Alzheimer's drug
New Alzheimer's drug is the 'beginning of the end' | Professor Michael Woodward
New Alzheimer's drug approved in the U.S.
A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
How a new kind of drug could change the future of Alzheimer’s
Alzheimer's drug hailed as breakthrough, but may have side effects
FDA approves controversial Biogen Alzheimer's drug | DW News
Warnings Canada isn’t prepared for ‘turning point’ Alzheimer treatments
US approves controversial new Alzheimer’s drug
New Alzheimer's drug slows disease by a third - BBC News
US FDA approves 1st new Alzheimer’s drug in nearly 20 years
The New Alzheimer’s Drug: What is Leqembi?
New Alzheimer's Medication Treatment
